JP2003502278A5 - - Google Patents

Download PDF

Info

Publication number
JP2003502278A5
JP2003502278A5 JP2000593602A JP2000593602A JP2003502278A5 JP 2003502278 A5 JP2003502278 A5 JP 2003502278A5 JP 2000593602 A JP2000593602 A JP 2000593602A JP 2000593602 A JP2000593602 A JP 2000593602A JP 2003502278 A5 JP2003502278 A5 JP 2003502278A5
Authority
JP
Japan
Prior art keywords
alkoxy
alkyl
hydrogen
substituted
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2000593602A
Other languages
English (en)
Japanese (ja)
Other versions
JP2003502278A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2000/000192 external-priority patent/WO2000042034A1/en
Publication of JP2003502278A publication Critical patent/JP2003502278A/ja
Publication of JP2003502278A5 publication Critical patent/JP2003502278A5/ja
Withdrawn legal-status Critical Current

Links

JP2000593602A 1999-01-15 2000-01-13 新規のn−オキシド Withdrawn JP2003502278A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP99100693.3 1999-01-15
EP99100693 1999-01-15
PCT/EP2000/000192 WO2000042034A1 (en) 1999-01-15 2000-01-13 Phenanthridine-n-oxides with pde-iv inhibiting activity

Publications (2)

Publication Number Publication Date
JP2003502278A JP2003502278A (ja) 2003-01-21
JP2003502278A5 true JP2003502278A5 (https=) 2007-03-01

Family

ID=8237350

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000593602A Withdrawn JP2003502278A (ja) 1999-01-15 2000-01-13 新規のn−オキシド

Country Status (12)

Country Link
US (1) US6534519B1 (https=)
EP (1) EP1147103B1 (https=)
JP (1) JP2003502278A (https=)
AT (1) ATE294793T1 (https=)
AU (1) AU2290000A (https=)
CA (1) CA2359449A1 (https=)
DE (1) DE60019894T2 (https=)
DK (1) DK1147103T3 (https=)
ES (1) ES2241571T3 (https=)
PT (1) PT1147103E (https=)
SI (1) SI1147103T1 (https=)
WO (1) WO2000042034A1 (https=)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1650193A3 (en) * 1999-01-15 2006-10-04 ALTANA Pharma AG 6-Phenylphenanthridines with PDE-IV inhibiting activity
CA2396026A1 (en) 2000-01-11 2001-07-19 Byk Gulden Lomberg Chemische Fabrik Gmbh Phenanthridine-n-oxides
PT1303506E (pt) 2000-07-14 2005-06-30 Altana Pharma Ag 6-heteroarilfenantridinas
CA2495827C (en) * 2002-08-29 2012-05-08 Altana Pharma Ag 2-hydroxy-6-phenylphenanthridines as pde-4 inhibitors
ES2281658T3 (es) 2002-08-29 2007-10-01 Nycomed Gmbh 3-hidroxi-6-fenilfenantridinas como inhibidores de pde-4.
EP1658270A1 (en) * 2003-07-31 2006-05-24 ALTANA Pharma AG Novel 6-phenylphenantridines
CA2533636A1 (en) * 2003-07-31 2005-02-10 Altana Pharma Ag Novel 6-phenylphenanthridines
US20050187278A1 (en) * 2003-08-28 2005-08-25 Pharmacia Corporation Treatment or prevention of vascular disorders with Cox-2 inhibitors in combination with cyclic AMP-specific phosphodiesterase inhibitors
WO2005023253A1 (en) * 2003-09-05 2005-03-17 Altana Pharma Ag Use of pde4 inhibitors for the treatment of diabetes mellitus
AU2005212857B2 (en) 2004-02-18 2011-04-28 Takeda Gmbh Novel guanidinyl-substituted hydroxy-6-phenylphenenthridines as effective phosphodiesterase (PDE) 4 inhibitors
AR049419A1 (es) * 2004-03-03 2006-08-02 Altana Pharma Ag Hidroxi-6-fenilfenantridinas sustituidas con heterociclilo
CN104803974A (zh) 2004-03-03 2015-07-29 塔科达有限责任公司 新的羟基-6-杂芳基菲啶及其作为pde4抑制剂的用途
JP2007527901A (ja) * 2004-03-10 2007-10-04 アルタナ ファルマ アクチエンゲゼルシャフト アミド置換された新規のヒドロキシ−6−フェニルフェナントリジン及びpde4インヒビターとしてのそれらの使用
ES2337083T3 (es) 2005-03-02 2010-04-20 Nycomed Gmbh (2r,4ar,10br)-6-(2,6-dimetoxipiridin-3-il)-9-exoti-8-metoxi-1,2,3,4,4a,10b-hexahidrofenantridin-2-ol, sal de hc1.
AU2006222060B2 (en) 2005-03-08 2011-09-01 Takeda Gmbh Roflumilast for the treatment of diabetes mellitus
MX2010003155A (es) 2007-10-04 2010-04-01 Hoffmann La Roche Derivados de ciclopropil aril amida y uso de los mismos.
WO2013106547A1 (en) 2012-01-10 2013-07-18 President And Fellows Of Harvard College Beta-cell replication promoting compounds and methods of their use

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5455252A (en) * 1993-03-31 1995-10-03 Syntex (U.S.A.) Inc. Optionally substituted 6,8-quinolines
US5475003A (en) * 1994-03-03 1995-12-12 Syntex (U.S.A.) Inc. 8-phenylcyclopentenoquinoline and 8-phenylcyclohexenoquinoline derivatives
CA2143143A1 (en) * 1994-03-08 1995-09-09 Toshihiko Tanaka 3-phenylpyrrolidine derivatives
US5466697A (en) * 1994-07-13 1995-11-14 Syntex (U.S.A.) Inc. 8-phenyl-1,6-naphthyridin-5-ones
UA48216C2 (uk) 1996-01-31 2002-08-15 Бік Гулден Ломберг Кеміше Фабрік Гмбх Фенантридини та лікарський засіб для лікування захворювань дихальних шляхів
US6127378A (en) 1996-03-26 2000-10-03 Byk Gulden Lomberg Chemische Fabrik Gmbh Phenanthridines substituted in the 6 position
WO1997035854A1 (de) * 1996-03-26 1997-10-02 Byk Gulden Lomberg Chemische Fabrik Gmbh Neue in 6-position substituierte phenanthridine
GB9622386D0 (en) 1996-10-28 1997-01-08 Sandoz Ltd Organic compounds
EE03829B1 (et) 1996-11-11 2002-08-15 Byk Gulden Lomberg Chemische Fabrik Gmbh Bensonaftüridiinid, nende kasutamine bronhiaalravimi valmistamiseks ning neid sisaldav ravim
GB9626643D0 (en) 1996-12-21 1997-02-12 Astra Pharma Prod Compounds
JP2001514640A (ja) 1997-03-07 2001-09-11 ビイク グルデン ロンベルク ヒエーミツシエ フアブリーク ゲゼルシヤフト ミツト ベシユレンクテル ハフツング 新規のテトラゾール
CA2291153A1 (en) 1997-06-03 1998-12-10 Byk Gulden Lomberg Chemische Fabrik Gmbh Benzonaphthyridine
DE69822162T2 (de) 1997-07-25 2005-01-27 Altana Pharma Ag Neue tetrazolderivate
AU5970199A (en) 1998-08-31 2000-03-21 Byk Gulden Lomberg Chemische Fabrik Gmbh Benzonaphthyridine-n-oxides comprising a pde3 and pde4 inhibiting activity

Similar Documents

Publication Publication Date Title
JP2003502278A5 (https=)
JP2002534508A5 (https=)
AU780678B2 (en) New use of compounds as antibacterial agents
JP2002517491A5 (https=)
JP2003501474A5 (https=)
EP1236719A4 (en) NOVEL HETEROCYCLIC COMPOUNDS AND SALTS THEREOF, USE OF THESE COMPOUNDS IN MEDICINE
JP2006508913A5 (https=)
JP2003500442A5 (https=)
JP2010529147A5 (https=)
JP2007517043A5 (https=)
JP2004501964A5 (https=)
MXPA05013712A (es) Derivados de acido propionico, utiles en el tratamiento de trastornos de lipidos.
SE0104341D0 (sv) New use
JP2002534506A5 (https=)
JP2004505004A5 (https=)
JP2002030084A5 (https=)
RU99101081A (ru) Режим введения ингибиторов н+, к+-атфазы
JP2003502367A5 (https=)
JP2002534507A5 (https=)
KR960022472A (ko) 3-페닐이소퀴놀-1(2h)-온 유도체와 그것의 제법 및 치료학적 이용
EP1184034A3 (en) Oral drug composition containing a verapamil derivative as a drug-absorption promotor
JP2001520994A5 (https=)
WO2003082329A3 (en) Compositions and compounds for use as molecular adjuvant for a nicotine vaccine
JP2003513075A5 (https=)
JP2003513066A5 (https=)